In this article Dr. Jeff Boden of of the global branding consultancy Kaleio, Inc. details how ibrexafungerp got its name Authored By: Jeff Boden, Ph.D. Article Posted: 22 April 2021 Ibrexafungerp is a novel antiungal agent that acts as an inhibitor of β(1-3)-glucan-synthase.  The product is differentiated from competitors in the antifungal space … [Read more...]

In this article an infectious diseases pharmacist identifies and discusses five challenges with creating and managing institutional guidelines for infectious diseases.  Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted: 21 April 2021 A recent study published in JAMA assessing the appropriateness of antimicrobial prescribing in … [Read more...]

In this article, three resources pharmacists can use to improve their antimicrobial stewardship research skills are identified.  Composed by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Date Published: 28 March 2021 Upon publishing this article I searched Pubmed for the term "antimicrobial stewardship" and it returned 7,962 results.  When items … [Read more...]

In this article five things to know about treating Mycobacterium abscesses are discussed.  Authors: Hannah Brokmeier, Pharm.D. (PGY-1 resident) and Cassandra Schmitt, Pharm.D. (PGY-1 resident)  Mentors: Christina G Rivera, Pharm.D., BCPS, AAHIV-P and Ryan W Stevens, Pharm.D., BCPID  Article Posted 10 February 2021 Mycobacterium abscessus (MABS) is … [Read more...]

In this article an infectious diseases pharmacist in India provides insights about antimicrobial stewardship in her country.  Interview with: Grace Mary John, Pharm.D. Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted: 3 February 2020 Antibiotic use and resistance varies geographically, but across the world antimicrobial … [Read more...]